EO decisions and CED recommendations

Information on drug funding decisions based on Executive Officer (EO) decisions and Committee to Evaluate Drugs (CED) recommendations. This information is intended for medical professionals and drug manufacturers.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Recommandations du DG et du CEM
Update Frequency unknown
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person {"en": "Health", "fr": "Health"}
Contact Email
Data Dictionary ["economy"]
Open Canada Date Published 2023-10-20 00:00:00
Open Canada Date Modified
Open Canada Subject ["government_and_politics"]
Open Canada Keywords {"en": ["Données Ontario", "Committee to Evaluate Drugs", "CED recommendations", "drug funding decisions", "Ontario drug review"], "fr-t-en": ["Ontario data", "Comité d'évaluation des médicaments", "Recommandations du CED", "décisions relatives au financement des médicaments", "Programme d'évaluation des médicaments en Ontario"]}
Open Canada Collection federated
Principal Organization
Reference Data
Official Source